Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 226 AL 240

Dynamic dual roles of gut microbial metabolites in Alzheimer's disease: Translational insights for gut-brain axis interventions

Ye X, Jing X, Li Z, Jia L, Zhong F, Luo XG.

Microbiol Res. 2026 Oct;311:128587. doi: 10.1016/j.micres.2026.128587. Epub 2026 Jun 11.

Beyond target engagement: RNA therapeutics and the neuroimmune challenge in tauopathies

Breen EA.

J Prev Alzheimers Dis. 2026 Aug;13(7):100626. doi: 10.1016/j.tjpad.2026.100626. Epub 2026 Jun 15.

Next-generation intranasal delivery nano-platforms for targeted brain therapy of Alzheimer's disease

Malaiya A, Kenwat R, Mamgain A, Paliwal SR, Sulakhiya K, Maiti S, Paliwal R.

Nanomedicine (Lond). 2026 Jun;21(12):1775-1795. doi: 10.1080/17435889.2026.2685131. Epub 2026 Jun 16.

Role of suvorexant in Alzheimer's disease: Targeting sleep, orexin signaling, and disease pathophysiology

Ahmed Abbasi A, Norouziyan F, Moradikor N.

J Alzheimers Dis. 2026 Aug;112(4):1700-1716. doi: 10.1177/13872877261461161. Epub 2026 Jun 18.

IL-4 in Alzheimer's Disease-Mechanisms and Therapeutic Potential

Liu G, Li W, Chen J, Xu S, Liu X, Wang Z, Yang Q, Xie A, Du Y.

Mol Neurobiol. 2026 Jun 20;63(1):708. doi: 10.1007/s12035-026-06003-7.

Reprogramming Neuroinflammation: Mitochondrial Targets and Immune Checkpoint Inhibitors in Alzheimer's Disease

Kumar N, Mir PA, Bhutia GT, Chaudhary P, Kaur G, Alam Q, Pawar SD, Gupta SK.

Mol Neurobiol. 2026 Jun 22;63(1):712. doi: 10.1007/s12035-026-05983-w.

Neuroinflammation-centered pathophysiology and therapeutic strategy design in Alzheimer's disease: Cutting-edge developments

Li D, Zhang Z, Lu L, Liu J, Cai W, Hou J, Lu Y, Yu G.

Cell Signal. 2026 Oct;146:112689. doi: 10.1016/j.cellsig.2026.112689. Epub 2026 Jun 26.

From synapses to tangles: PDE inhibitors as therapeutic modulators in Alzheimer's disease

Bagri K, Damde P, Bhatia A, Deshmukh R.

Eur J Pharmacol. 2026 Jul 15;1030:179084. doi: 10.1016/j.ejphar.2026.179084. Epub 2026 Jun 23.

Battling Parkinson's and Alzheimer's: The Neuroprotective Power of Carnosic Acid

Goyal A, Verma A, Kumari A, Mishra MK.

J Biochem Mol Toxicol. 2026 Jul;40(7):e70991. doi: 10.1002/jbt.70991.

Neuroinflammation in Alzheimer's Disease (AD) and Glioblastoma (GBM): Shared Mechanisms and Therapeutic Insights

Mikołajczak K, Chmiel J, Leszek J.

Cells. 2026 Jun 19;15(12):1111. doi: 10.3390/cells15121111.

The Biological Basis, Mechanisms of Action, and Optimization Strategies of Exosomes Derived from Mesenchymal Stem Cells for the Treatment of Alzheimer's Disease

Zhang C, Long W, Ni J, Chen Z, Wu X, Li M, Du F, Zhao Y, Shen J, Cho CH, He X, Xiao Z.

Mol Neurobiol. 2026 Jun 25;63(1):723. doi: 10.1007/s12035-026-06002-8.

The Role of Sphingosine-1-Phosphate Signaling in Cerebral Ischemia/Reperfusion Injury and Alzheimer's Disease Pathology

Czubowicz K, Motyl JA, Wencel A, Strosznajder RP.

Int J Mol Sci. 2026 Jun 9;27(12):5200. doi: 10.3390/ijms27125200.

Advances in 3D cell culture models for alzheimer's disease drug discovery

Valdivia-Aviña K, Ochoa-Hugo SE, Hernández-Sapiéns MA, Canales-Aguirre AA.

Expert Opin Drug Discov. 2026 Jul;21(7):761-777. doi: 10.1080/17460441.2026.2691833. Epub 2026 Jun 27.

HDAC3 in Alzheimer's Disease: established evidence, unresolved questions, and translational priorities

Luo J, Wu X, Jiang D, He G, Du Y.

Mol Biol Rep. 2026 Jun 27;53(1):1017. doi: 10.1007/s11033-026-12213-y.

Brain Endothelial Glycocalyx as a Blood-Facing Translational Interface in Alzheimer's Disease: Beyond "Leaky" Barriers Toward Repair-First Stratification

Zhang C, Fang D, Zhang L.

Drug Des Devel Ther. 2026 Jun 26;20:619901. doi: 10.2147/DDDT.S619901. eCollection 2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias